Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Neuroendocrine
  • Oncolytic Virotherapy
  • Oncolytic Viruses
  • Picornaviridae

abstract

  • SVV-001 has potent cytolytic activity and high selectivity for tumor cell lines having neuroendocrine properties versus adult normal cells. Systemically administered SVV-001 has potential for the treatment of metastatic neuroendocrine cancers.

publication date

  • November 7, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5261858

Digital Object Identifier (DOI)

  • 10.1093/jnci/djm198

PubMed ID

  • 17971529

Additional Document Info

start page

  • 1623

end page

  • 33

volume

  • 99

number

  • 21